{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:34:57Z","timestamp":1787016897180,"version":"build-2736575974"},"reference-count":17,"publisher":"BMJ","issue":"5","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Arch Dis Child Fetal Neonatal Ed"],"accepted":{"date-parts":[[2014,5,19]]},"published-print":{"date-parts":[[2014,9]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Subcutaneous fat necrosis (SCFN) is a rare form of panniculitis in infants that generally occurs following birth trauma, meconium aspiration, or therapeutic cooling. Severe hypercalcaemia occurs in a subset of patients, but data on its presentation, management and outcomes are limited. This report details the clinical course and complications of infants treated for severe hypercalcaemia (peak serum calcium \u22653.0\u2005mmol\/L) due to SCFN.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Chart review of all infants with SCFN seen at a single paediatric centre over a 13-year period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients<\/jats:title>\n                    <jats:p>Seven infants with SCFN developed severe hypercalcaemia, with median peak serum calcium 4.1\u2005mmol\/L (range 3.3\u20135.1).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Severe hypercalcaemia occurred before 6\u2005weeks of age, and was asymptomatic in 3\/7 patients (43%). Most patients were treated with intravenous hydration, furosemide, glucocorticoids and low-calcium formula, which restored normocalcaemia in a median of 9\u2005days (range 2\u201342). Fever developed during treatment in 4\/7 infants (57%): two patients had bacterial infections and two had no infectious source identified. Nephrocalcinosis was present in 5\/6 patients (83%) who were evaluated by renal ultrasound. Nephrocalcinosis failed to resolve in all cases over a median follow-up of 20\u2005months (range 8\u201348), but no renal dysfunction was observed. Eosinophilia, which has not been reported previously in SCFN, was present in 6\/7 patients (86%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In this largest series to date of infants with severe hypercalcaemia due to SCFN, novel findings include the common occurrence of fever and a high incidence of persistent nephrocalcinosis without evidence of adverse renal outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/archdischild-2014-306069","type":"journal-article","created":{"date-parts":[[2014,6,7]],"date-time":"2014-06-07T04:06:58Z","timestamp":1402114018000},"page":"F419-F421","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":54,"title":["Severe hypercalcaemia due to subcutaneous fat necrosis: presentation, management and complications"],"prefix":"10.1136","volume":"99","author":[{"given":"Daniel E","family":"Shumer","sequence":"first","affiliation":[{"name":"Division of Endocrinology, Boston Children's Hospital, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidhu","family":"Thaker","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Boston Children's Hospital, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George A","family":"Taylor","sequence":"additional","affiliation":[{"name":"Department of Radiology, Boston Children's Hospital, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ari J","family":"Wassner","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Boston Children's Hospital, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2014,6,6]]},"reference":[{"key":"2025090511070982000_99.5.F419.1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1470.2003.20315.x"},{"key":"2025090511070982000_99.5.F419.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(87)70056-5"},{"key":"2025090511070982000_99.5.F419.3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2007.07782.x"},{"key":"2025090511070982000_99.5.F419.4","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1470.1999.00101.x"},{"key":"2025090511070982000_99.5.F419.5","first-page":"176","article-title":"Hypercalcemia: pathogenesis, clinical manifestations, differential diagnosis, and managment","volume-title":"Primer on the metabolic bone diseases and disorders of mineral metabolism","volume":"26","author":"Shane","year":"2006"},{"key":"2025090511070982000_99.5.F419.6","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2010-3508"},{"key":"2025090511070982000_99.5.F419.7","doi-asserted-by":"publisher","DOI":"10.1258\/000456306778520106"},{"key":"2025090511070982000_99.5.F419.8","doi-asserted-by":"publisher","DOI":"10.1159\/000092602"},{"key":"2025090511070982000_99.5.F419.9","first-page":"1004","article-title":"Complication of subcutaneous fat necrosis of the newborn: a case report and review of the literature","volume":"3","author":"Ghergherehchi","year":"2008","journal-title":"Res J Biol Sci"},{"key":"2025090511070982000_99.5.F419.10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1470.1995.tb00123.x"},{"key":"2025090511070982000_99.5.F419.11","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(79)80536-3"},{"key":"2025090511070982000_99.5.F419.12","doi-asserted-by":"publisher","DOI":"10.1055\/s-0030-1262208"},{"key":"2025090511070982000_99.5.F419.13","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2006-2639"},{"key":"2025090511070982000_99.5.F419.14","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-006-0217-0"},{"key":"2025090511070982000_99.5.F419.15","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-008-0797-8"},{"key":"2025090511070982000_99.5.F419.16","doi-asserted-by":"publisher","DOI":"10.1177\/000992280104000407"},{"key":"2025090511070982000_99.5.F419.17","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1365-2133.2008.08844.x","article-title":"Expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in subcutaneous fat necrosis","volume":"160","author":"Farooque","year":"2008","journal-title":"Br J Dermatol"}],"container-title":["Archives of Disease in Childhood - Fetal and Neonatal Edition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/archdischild-2014-306069","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T18:32:24Z","timestamp":1757097144000},"score":1,"resource":{"primary":{"URL":"https:\/\/fn.bmj.com\/lookup\/doi\/10.1136\/archdischild-2014-306069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,6]]},"references-count":17,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2014,8,12]]},"published-print":{"date-parts":[[2014,9]]}},"alternative-id":["10.1136\/archdischild-2014-306069"],"URL":"https:\/\/doi.org\/10.1136\/archdischild-2014-306069","relation":{},"ISSN":["1359-2998","1468-2052"],"issn-type":[{"value":"1359-2998","type":"print"},{"value":"1468-2052","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,6]]}}}